This compound is widely utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). It serves as a key component in designing molecules that can selectively degrade disease-causing proteins by recruiting E3 ubiquitin ligases. Its application is prominent in cancer research, where it helps in the degradation of oncogenic proteins, offering a potential therapeutic strategy. Additionally, it is used in biochemical studies to understand protein-protein interactions and cellular signaling pathways, aiding in the discovery of novel drug targets. Its role in advancing precision medicine and targeted therapies makes it a valuable tool in modern biomedical research.